OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study
A prospective, single center, single arm phase 2 cohort feasibility study of the OURA ring in adult MDS patients. Patients with MDS will wear the OURA ring and upload biometrics weekly. Quality of life measures will be clinically evaluated and correlated with biometrics. We hypothesize that it will be feasible for MDS patients to wear the OURA ring 70% of the time for 3 months.
- EligibilityCriteria: Inclusion Criteria:  Provision of signed and dated informed consent form Stated willingness to comply with all study procedures and availability for the duration of the study Male or female, aged 18 or older Able to read, write and speak English or French (non-English or French speaking patients may participate if appropriate translation is used) Able to provide informed consent Diagnosed with Myelodysplastic Syndrome using WHO 2022 criteria (12) Ability to wear the OURA ring and operate the associated smart-phone app, and willing to adhere to the study regimen Willing to operate and charge a smart phone loaded with the OURA ring app  Exclusion Criteria:  Performance status ECOG > 3. Cognitive or physical impairment preventing the usage or utilization of the OURA ring and smart phone. - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult - StudyPopulation: Our study population is in adult patients with MDS. There are no limitations with regards to age or gender. - SamplingMethod: Non-Probability Sample